STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118 | -96.9% | 29,789 | -91.7% | 0.00% | -100.0% |
| Q2 2023 | $3,816 | +21.2% | 358,922 | -5.0% | 0.00% | – |
| Q1 2023 | $3,148 | -13.7% | 377,801 | -4.4% | 0.00% | -100.0% |
| Q4 2022 | $3,647 | -99.9% | 395,107 | -4.2% | 0.00% | 0.0% |
| Q3 2022 | $5,295,000 | -3.8% | 412,343 | -1.1% | 0.00% | 0.0% |
| Q2 2022 | $5,505,000 | -38.3% | 416,721 | -1.7% | 0.00% | 0.0% |
| Q1 2022 | $8,922,000 | -15.1% | 423,863 | -3.3% | 0.00% | 0.0% |
| Q4 2021 | $10,514,000 | +22.4% | 438,247 | +29.8% | 0.00% | 0.0% |
| Q3 2021 | $8,588,000 | -34.1% | 337,582 | -12.9% | 0.00% | 0.0% |
| Q2 2021 | $13,041,000 | -46.1% | 387,423 | -37.8% | 0.00% | -50.0% |
| Q1 2021 | $24,205,000 | -47.9% | 623,192 | -16.9% | 0.00% | -60.0% |
| Q4 2020 | $46,424,000 | +274.6% | 749,626 | +102.6% | 0.01% | +400.0% |
| Q3 2020 | $12,394,000 | +32.9% | 370,093 | -5.4% | 0.00% | 0.0% |
| Q2 2020 | $9,326,000 | -4.7% | 391,358 | -8.5% | 0.00% | -50.0% |
| Q1 2020 | $9,790,000 | -29.2% | 427,522 | -12.5% | 0.00% | 0.0% |
| Q4 2019 | $13,835,000 | +68.4% | 488,513 | +27.8% | 0.00% | +100.0% |
| Q3 2019 | $8,216,000 | -25.3% | 382,313 | +1.4% | 0.00% | -50.0% |
| Q2 2019 | $10,994,000 | – | 376,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |